Swarajya
Our View
Magazine
Dashboards
Subscribe
Swarajya
Subscribe
Get App
Home
Dashboards
Magazine
Swarajya
Politics
Economics
Business
Culture
Infra
Defence
World
Books
Ideas
Science
Technology
Heritage
Archives
Subscriber login
Politics
Economics
Business
Culture
Infra
Defence
World
Books
Ideas
Science
Technology
Heritage
Archives
Bharat Biotech
Centre Unveils World’s First Made-In-India Covid Nasal Vaccine 'iNCOVACC' By Bharat Biotech
Swarajya Staff
Thursday, January 26, 2023 06:25 PM IST
Bharat Biotech's Intranasal COVID-19 Vaccine To Cost Rs 800 For Private Markets, Rs 325 For Govt Supplies
PTI
Tuesday, December 27, 2022 02:00 PM IST
Centre Signs PPP With Bharat Biotech For Development Plus Commercial Production Of Intranasal Covid-19 And Malaria Vaccines
Swarajya Staff
Sunday, March 27, 2022 01:51 PM IST
Bharat Biotech Gets DCGI Nod For Phase 3 Trials Of Its Intra-Nasal COVID-19 Vaccine
PTI
Friday, January 28, 2022 04:16 PM IST
Omicron Is Behaving More Rationally Than Politicians And Media, Who Are Part Of The Problem
R Jagannathan
Thursday, January 6, 2022 04:24 PM IST
Bharat Biotech Gets DCGI Panel's Approval For Phase 3 Trials Of Intranasal COVID-19 Vaccine As Booster Shot: Report
Swarajya Staff
Wednesday, January 5, 2022 05:29 PM IST
Bharat Biotech's Intranasal Covid-19 Vaccine Completes Phase 2 Trials: Krishna Ella
Bhaswati Guha Majumder
Monday, November 29, 2021 06:23 PM IST
UK Adds Bharat Biotech's Covaxin To Its List Of Approved COVID-19 Vaccines For International Travellers
Swarajya Staff
Tuesday, November 23, 2021 10:53 AM IST
Lost 10 Years Of Life In Past 18 Months Due To Stress And Excitement Of Developing Covaxin: Dr Krishna Ella
Swarajya Staff
Sunday, November 14, 2021 08:57 AM IST
Bharat Biotech Chairman Dr Krishna Ella Slams Biased Media Coverage And Domestic Politics Around Covaxin: "It Really Hurts"
Swarajya Staff
Friday, November 12, 2021 03:34 PM IST
Covaxin Phase 3 Trial Data Shows 77.8 Per Cent Efficacy Against Symptomatic COVID, Finds Study Published In Lancet
Swarajya Staff
Friday, November 12, 2021 10:05 AM IST
Booster Doses? Vaccination For Children? SUTRA Team Answers Your Questions
The SUTRA Team
Wednesday, November 10, 2021 11:43 AM IST
Zydus Cadila To Enter Vaccine Space By Supplying 1 Crore Of Its Plasmid DNA Vaccine Shots To Centre; Read Other Details Here
Bhaswati Guha Majumder
Tuesday, November 9, 2021 12:57 PM IST
US Biotech Company Ocugen Files IND Application With FDA For Bharat Biotech's Covaxin Clinical Trials
Bhaswati Guha Majumder
Thursday, October 28, 2021 02:33 PM IST
WHO Seeks 'Additional Clarifications' From Bharat Biotech For Covaxin To Conduct Final 'Risk-Benefit Assessment'
PTI
Wednesday, October 27, 2021 09:54 AM IST
What Can Possibly Explain WHO's Delay In Approving Covaxin?
Bhaswati Guha Majumder
Wednesday, October 20, 2021 07:16 PM IST
Bharat Biotech's Covaxin For Children To Get Approval For Emergency Use; Two Other Vaccines Are On The Pipeline
Bhaswati Guha Majumder
Wednesday, October 13, 2021 01:00 PM IST
GSK-Bharat Biotech Partnership To Produce World's First Malaria Vaccine Approved By WHO
Swarajya Staff
Friday, October 8, 2021 10:33 AM IST
Final Decision On Approval To Bharat Biotech's Covaxin To Be Taken Next Week: WHO
Swarajya Staff
Wednesday, October 6, 2021 10:38 AM IST
India To Buy 27-28 Crore COVID-19 Vaccine Doses From SII, Bharat Biotech In October: Report
Swarajya Staff
Friday, October 1, 2021 10:32 AM IST
Load More